Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-09

Clinical Trial Update: Effect of Olive Leaf Extracts on Endothelial Dysfunction in Patients With Acute Coronary Syndrome [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial is evaluating olive leaf extract for improving endothelial dysfunction in patients with acute coronary syndrome across Phase 2 and Phase 3, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Olive Leaf Extract (Olea europaea leaf extract)

Snippet

Sponsor: University of Monastir | Conditions: Acute Coronary Syndrome (ACS), Reactive Hyperemia | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING